Today, the FDA is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.
fda.gov/news-events/press-an…
ALT Text reads "FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs"
During her session for the participants of our DHR training course #HDM2024, Dr Prajakta Dandekar-Jain, (@ICTMumbai1933) spoke about the retina-on-chip models and use of these three-dimensional in-vitro models for biological and pre-clinical research.
Congratulations Dr Pratishtha Pandey, IITD Alum, takes over as Advisor & Scientist G, Head R & D Infrastructure Division, DST, to know about her shorturl.at/lLY57@Pratishtha_DST
@BIRAC_2012 supported hands on training on 3D cell culture at ICT, Mumbai from 29 Jan - 1st Feb 2024. The four day training has around 25 participants from industry/ startup/academia and hands-on sessions on operation and working of organ-on-chips, Organoid development.
Here's the team behind Biosimilar Workshop, whose hard work and dedication ensured that the event was a resounding success! Dr. Ratnesh Jain & Dr. Prajakta Jain empowered each core team member to excel in their roles.
Stay tuned for exciting updates on our next workshop! 🌴💼📊
Dive into the future of biopharma watch Dr. Parthasarathy Sampathkumar from Biocon Biologics Ltd. shares his experience as he moderated a session on PAT, Data Analytics, and Industry 4.0 at the Biosimilar Workshop.
With Biologics 2025, It's only going to be Bigger and Better!
Dr. @RajarshiPal16, currently the chief scientist at @EyestemResearch, will be giving a talk in our first talk session: 'Advances in organoids and tumoroid developments: characterization and applications'.
Listen to him and other experts talk on various topics on #3dcellculture!
Meet Dr. Bala Reddy, Director at Hetero Biopharma, is influencing the future of biotech with over 20 years of experience with biosimilars. By actively participating in the 2023 Biosimilar Workshop. Stay tune for interesting updates on our upcoming workshop!
#BiologicsWorkshop2025
Watch Dr. @annu_uppal, from the US Pharmacopeia-India, discuss how the Biosimilar Workshop 2023, provided a platform to #network and bridge the gap between #academia and #industry in the #research sector.
Get ready for an even bigger and better #Biologics#workshop! Stay tuned!